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1  | INTRODUC TION
Vascular dementia (VaD) as the second most common cognitive dis‐
orders, following Alzheimer’s disease (AD), is caused by a series of 
cardiac‐cerebral vascular conditions that are characterized by loss of 
cognitive functions.1,2 The worldwide number of patients with VaD is 
estimated to rise because no effective prevention or treatment strat‐
egy is available.3 Progress toward finding effective treatments for VaD 
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Summary
Aims: Acupuncture has been reported to affect vascular dementia through a variety 
of molecular mechanisms. An isobaric tag for relative and absolute quantification 
(iTRAQ) with high‐resolution liquid chromatography‐tandem mass spectrometry (LC‐
MS/MS) analyses makes it possible to attain a global profile of proteins. Hence, we 
used an iTRAQ‐LC‐MS/MS strategy to unravel the underlying mechanism of 
acupuncture.
Methods: Wistar rats were subjected to vascular dementia with bilateral common 
carotid occlusion. Acupuncture was intervened for 2 weeks at 3 days after surgery. 
The Morris water maze was used to assess the cognitive function. Proteins were 
screened by quantitative proteomics and analyzed by bioinformatic analysis. Four 
differentially expressed proteins (DEPs) were validated by western blot. The reactive 
oxygen species (ROS) production, neuron cell loss, and long‐term potentiation (LTP) 
were determined after western blot.
Results: Acupuncture at proper acupoints significantly improved cognitive function. 
A total of 31 proteins were considered DEPs. Gene ontology (GO) analysis showed 
that most of the DEPs were related to oxidative stress, apoptosis, and synaptic func‐
tion, which were regarded as the major cellular processes related to acupuncture 
effect. Western blot results confirm the credibility of iTRAQ results. Acupuncture 
could decrease ROS production, increase neural cell survival, and improve LTP, which 
verified the three major cellular processes.
Conclusion: Acupuncture may serve as a promising clinical candidate for the treat‐
ment of vascular dementia via regulating oxidative stress, apoptosis, or synaptic 
functions.
K E Y W O R D S
acupuncture, iTRAQ, proteomics, vascular dementia
has proved even more elusive than for AD. Cholinesterase inhibitors 
and memantine as two best studied treatments, both of which are 
proven therapy for AD, have not been shown to be effective for VaD.4,5
Acupuncture is a nonpharmacological therapy that has been 
extensively tested in patients with VaD in China.6,7 Several clinical 
studies have shown therapeutic benefits of acupuncture in patients 
with VaD.8,9 However, the molecular events associated with acu‐
puncture are not clearly understood. Acupuncture has been shown 
to protect cells from the neurotoxicity induced by brain ischemia by 
exhibiting antioxidative and anti‐inflammatory effects or regulating 
various signaling pathway.10‒13 Given that, there may be not a single 
or a small amount of protein, but a variety of candidate proteins 
involved in the acupuncture treatment benefits. Moreover, among 
the 361 acupoints, ST36 and GV20 are the most commonly used 
acupoints for the treatment of neurological diseases.11
The development of quantitative proteomics technologies using 
the isobaric labeling strategy has made it possible to obtain global 
physiological profiles of VaD rats with acupuncture at the protein 
level. An isobaric tag for relative and absolute quantification (iTRAQ) 
is a common technique widely used in various areas for simultane‐
ous	quantification	of	4‐	or	8‐plex	samples.14 The subsequent use of 
high‐resolution liquid chromatography‐tandem mass spectrometry 
(LC‐MS/MS) analyses provides accurate relative ratio between pro‐
tein concentrations, presenting in different samples.15
Despite having immense potential to elucidate the underlying 
mechanism of acupuncture, proteomics studies of VaD treated by acu‐
puncture are lacking. Therefore, this study aims to utilize LC‐MS/MS 
coupled with iTRAQ labeling to identify and quantify the differentially 
expressed proteins in a VaD rat model. Bioinformatic analysis will be 
used to select differently expressed proteins related to the mecha‐
nisms of acupuncture on rats with VaD. These findings may enhance 
understanding of the underlying mechanisms of acupuncture on VaD.
2  | MATERIAL S AND METHODS
2.1 | Animals
Eight‐week‐old male Wistar rats (280‐320 g, housed under 12‐hours 
light and dark conditions with food and water available ad libitum) 
were used in this study. All animals were provided by the Vital River 
Laboratory Animal Technology Co., Ltd (Beijing, China). This study 
was carried out in accordance with the recommendations of the 
Guide for the Care and Use of Laboratory Animals and approved 
by the Ethics Committee for Animal Experimentation and Use 
Committee of China Academy of Chinese Medical Sciences.
2.2 | Experimental design
2.2.1 | Experiment 1
To compare the effect of acupuncture at proper acupoints on 
the cognitive deficits with that of placebo acupuncture (the same 
stimulation was applied to a non‐acupoint) in a vascular dementia 
model,	we	randomly	divided	24	rats	into	4	groups:	sham,	2VO	(model	
only), Acu (model with acupuncture at proper acupoint), and Non‐
acu (model with acupuncture at a non‐acupoint).
2.2.2 | Experiment 2
To determine the beneficial effect of acupuncture in the hippocam‐
pus of vascular dementia rats at protein level, we divided a further 
18 rats (n = 6 each group) into 3 groups: sham, 2VO, and Acu.
2.2.3 | Experiment 3
To verify the beneficial effect of acupuncture which was confirmed 
by iTRAQ‐based proteomics, we divided a further 18 rats (n = 6 each 
group) into 3 groups: sham, 2VO, and Acu.
2.2.4 | Experiment 4
To clarify the role of S100b in acupuncture neuroprotective effect, 
we	divided	a	further	24	rats	(n	=	6	each	group)	into	4	groups:	2VO,	
Acu, 2VO +S100b siRNA, and 2VO +Control siRNA.
2.3 | Bilateral common carotid arteries occlusion
Bilateral surgical ligation of the common carotid arteries (2‐vessel 
occlusion, 2VO) in rats remains the most frequently used model of 
vascular dementia.16,17 Rats were anesthetized intraperitoneally 
with	2.5%	pentobarbital	sodium	(50	mg/kg).	The	bilateral	common	
carotid	arteries	were	exposed	and	then	ligated	with	5‐0	silk	sutures.	
In the sham group, the same operations were performed without 
artery occlusion.
2.4 | Acupuncture treatment
Three days after surgery, acupuncture was performed at ST36 and 
GV20	 (Acu)	 or	 at	 non‐acupoint	 (Non‐acu)	 once	 daily	 for	 14	days	
(1 day rest after 6 days treatment). Sterilized disposable needles 
(0.3	×	40	mm,	Hwato,	China)	were	 selected	 to	 stimulate	ST36	and	
GV20 or non‐acupoints, and the location and the operated method 
of acupoints are shown in Table 1. The rats in the sham and 2VO 
group were given the same account catching‐grasping stimulus with‐
out the acupuncture stimulation.
2.5 | Morris water maze (MWM)
To assess spatial learning and memory, rats were trained and tested 
in MWM after acupuncture as described before.18 In brief, each rat 
was	 trained	 3	 times	 per	 day	 for	 5	 consecutive	 days.	 The	 rat	 was	
free to swim until it found the platform or was guided in place if 
the animal does not reach the platform during 90 seconds. Before 
removed from the pool, each rat was placed on the platform for 
10 seconds. On day 6, the hidden platform was removed and the 
rats were allowed to swim freely for 90 seconds. We recorded the 
quadrant dwell time in the target quadrant and calculated it by the 
computer with a tracking system (TopScan Lite Animal Behavior 
Analysis System, USA).
2.6 | Electrophysiological recordings
Rats were fixed with a stereotaxic frame (SR‐6 N; Narishige, Japan) 
after anesthetized with urethane (1.2 g/kg, IP). Electrodes were 
positioned as our previous study.18 The lateral prepenetrating (PP) 
was stimulated during the long‐term potentiation (LTP) experi‐
ments. After a 30‐minute stable baseline recording, LTP was in‐
duced	 by	 high‐frequency	 stimulation	 consisting	 of	 4	 trains	 of	 30	
stimuli	 	applied	at	500	Hz	with	an	intertrain	interval	of	10	seconds.	
After  tetanic stimulation, the field excitatory postsynaptic potential 
(fEPSP) was recorded for 60 minutes, and the fEPSP slope level was 
present by the ratio of absolute of fEPSP slope to baseline value.
2.7 | Sample collection
At the termination of the experiment, rats were euthanized with 
a sodium pentobarbital overdose (100 mg/kg). The brains were 
 removed, and the hippocampi were dissociated for protein extrac‐
tion and proteomics analysis. The remaining brains were sectioned 
and	were	immersed	in	4%	paraformaldehyde	to	fix	for	histopatho‐
logic evaluation.
2.8 | iTRAQ-based quantitative proteomic analyses
In this experiment, there were three groups of rats (n = 6 per group) 
to evaluate the proteome regulated by ischemia and acupuncture. 
Each group contained six hippocampus isolated from different ani‐
mals to minimize the surgical and biological variations between indi‐
vidual subjects.
2.8.1 | Sample preparation
Frozen tissues from hippocampus were ground and suspended in 
freshly	prepared	10%	TCA	in	0.2%	DTT‐containing	acetone.	After	30	
minutes	centrifugation	at	20	000	g	at	4°C,	the	pellet	was	collected	
and	resuspended	in	1.3	mL	of	0.2%	DTT	in	acetone,	then	centrifuga‐
tion	for	30	minutes	at	20	000	g	at	−20°C.	After	dissolved	in	8	mol/L
urea with protease inhibitor cocktail (Roche, Germany), the pellets 
were intermittent sonication for 20 seconds, followed by centri‐
fuged to collect the supernatant. DTT was added to the supernatant 
to a final concentration of 10 mmol/L and then water bathed for 1 
hour. After that, iodoacetamide was rapidly added to a final concen‐
tration	of	55	mmol/L	followed	by	standing	in	the	dark	for	1	hour.	The	
proteins	mixture	was	purified	by	adding	4‐fold	volume	cold	acetone	
and	 left	at	−20°C	 for	3	hours.	The	precipitated	proteins	were	col‐
lected	by	centrifuging	at	20	000	×	g	at	4°C	for	30	minutes	followed	
by	dissolving	in	the	reconstitution	buffer	containing	50%	TEAB	and	
0.1%	SDS.	Protein	contents	were	assayed	by	the	Bradford	assay.
2.8.2 | Protein digestion and peptide iTRAQ labeling
Samples (100 μg of proteins/condition) were digested with 3.3 μg 
trypsin	for	24	hours	at	37°C	and	then	digested	for	another	12	hours	
with a supplementary 1 μg trypsin. The peptides were vacuum cen‐
trifuged to dryness. Following trypsin digestion, the peptides were 
reconstituted and individually labeled with 8‐plex iTRAQ reagents 
(Applied	Biosystems,	USA)	 as	 follows:	 sham	 group	 (115	 tag),	 2VO	
group (118 tag), and Acu group (113 tag). The labeled peptides were 
combined and dried in a vacuum centrifuge.
2.8.3 | Strong cation exchange (SCX) 
Chromatography
The peptides were dried and reconstituted in Buffer A (10 mmol/L 
KH2PO4	in	25%	ACN;	pH	3.0)	and	fractionated	using	a	Phenomenex	
HPLC	 Luna	 SCX	 column	 (150*4.6	mm;	 5	μm; 100 A) (PolyLC, 
Columbia, MD). Then, a 76‐min gradient was adopted with Buffer B 
(10	mmol/L	KH2PO4	and	2	mol/L	KCl	in	25%	ACN;pH 3.0) to elute 
the peptides. The elution fractions were collected at 1‐min intervals 
and pooled into 16 fractions.
2.8.4 | LC and MS/MS analyses
The reconstituted peptides were analyzed with the Q‐Exactive mass 
spectrometer (Thermo Fisher Scientific, Waltham, MA, USA) coupled 
TA B L E  1   Acupuncture points and manipulations
Points Anotomind positions Manipulation
Twisting 
angle 
(degrees)
Frequency 
(per minutes) Time (s)
Zusanli (ST36) 2 mm lateral to the anterior tubercle of the tibia and 
5	mm	below	the	capitulum	fibulae	under	knee	
joint
Twirling reinforcing 
manipulation
<90 >120 30
Baihui (DU20) Midline of the head, approximately midway on the 
line connecting the apices of the auricles
Twirling reinforcing 
manipulation
<90 >120 30
Non‐acupoints On the bilateral hypochondrium, 10 mm above iliac 
crest
Moderate reinforc‐
ing‐reducing 
manipulation
90‐180 60‐120 45
with a nano high‐performance liquid chromatography (UltiMate 3000 
LC Dionex; Thermo Fisher Scientific) system. The iTRAQ‐labeled pep‐
tides were separated on a home‐packed nanobored C18 column with 
a	picofrit	nanospray	tip	(75	μm	ID	*	15	cm,	5	μm particles) using mobile 
phase	A	(0.1%	FA	in	2%	ACN)	and	phase	B	(0.1%	FA	in	100%	ACN).	
The Q‐Exactive was used with high energy collision dissociation (HCD) 
in each MS and MS/MS cycle. MS spectra were collected in the range 
350‐2000	m/z	 at	 a	 resolving	 power	 of	 70	000.	 The	 automatic	 gain	
control (AGC) target was set to 3 × 106, and the maximum ion time 
was	50	ms	MS/MS	analyses	were	set	at	a	resolving	power	of	17	500	
with a maximum ion time of 100 ms and a normalized collision energy 
of	28.	Precursor	ions	were	excluded	from	reselection	for	15	seconds.
2.8.5 | Proteomic data analysis and bioinformatics
The raw mass data were processed for the peptide data analysis using 
Proteome	Discoverer	1.4	 (ver.	1.4.0.288;	Thermo	Fisher	Scientific)	
with	a	false	discovery	rate	(FDR	=	N(decoy)*2/((N(decoy)	+	N(target)))	
<1%	and	expected	cutoff	or	ion	score	<0.05	(with	95%	confidence)	
for	searching	the	Uniprot_2015_rattus	database.	Protein	probabili‐
ties were assigned using the Protein Prophet algorithm, and proteins 
with at least two unique peptides were identified. The upregulated 
or downregulated proteins in all replicates with relative quantifica‐
tion P‐values	<0.05‐fold	and	1.2‐fold	changes	were	selected	as	being	
differentially expressed in the data. The following options were used 
to	identify	the	proteins:	peptide	mass	tolerance	=	±15	ppm,	MS/MS	
tolerance = 20 mmu, enzyme = trypsin, missed cleavage = 1, fixed 
modification: carbamidomethyl (C), variable modification: oxidation 
(M),	 Gln→Pyro‐Glu	 (N‐termQ),	 iTRAQ	 8plex	 (K),	 iTRAQ	 8plex	 (Y),	
and iTRAQ 8plex (N‐term), database pattern =decoy.
Gene ontology (GO) was performed using the bioinformatics anal‐
ysis tool DAVID (https://david.abcc.ncifcrf.gov) to determine the func‐
tional classifications of the identified proteins. The interactions among 
these proteins regarding the biological pathways were determined using 
Pathway Studio software and the Kyoto Encyclopedia of Genes and 
Genomes (KEGG) database to better understand these differentially 
expressed proteins in relation to the published literature. Significant 
pathway enrichment was defined as a corrected FDR of P	<	0.05.
2.9 | Western blotting validation
Western blot analyses were performed to validate the proteomics 
results.19	 The	 protein	 samples	were	 separated	 by	 10%	SDS‐PAGE	
gels and transferred to PVDF membranes. The membranes were 
blocked	with	5%	non‐fat	milk	in	TBS	and	then	incubated	overnight	
at	4°C	with	primary	antibodies,	including	antibodies	against	S100‐B	
(S100B),	copper	chaperone	for	superoxide	dismutase	(SOD1),	14‐3‐3	
protein	epsilon	(14‐3‐3e),	high	mobility	group	protein	B1	(HMGB1),	
and β‐actin (both at 1:1000; Abcam, USA). The membranes were 
then washed and incubated for 1 hour at room temperature with 
secondary	antibodies	 (1:5000;	Abcam,	USA),	and	the	 images	were	
captured using the Odyssey Infrared Imaging System (LI‐COR 
Biosciences, Nebraska USA).
2.10 | Nissl staining and dihydroethidium 
(DHE) staining
We used a cryostat to section the frozen tissues to a thickness of 
20 μm.	The	slides	were	immersed	in	0.2%	cresyl	violet	solution	for	
30	minutes	at	37˚C	followed	by	covered	with	a	xylene‐based	mount‐
ing medium. Another investigator who was blinded observed the 
sections by a light microscope (Olympus).
Frozen	 sections	 were	 loaded	 with	 5	µmol/L	 DHE	 (Molecular	
Probes)	at	37°C	for	60	minutes.	Reactive	oxygen	species	(ROS)	flu‐
orescence was measured by a DM 6000 B fluorescence microscope 
(Leica,	Germany)	 at	 excitation	515	nm	and	emission	585	nm.	Data	
were analyzed by the Fluoview software (Olympus).
2.11 | Microinjection into intracerebroventricular
S100b siRNA was purchased from GenePharma China Ltd (Shanghai, 
China).	The	sense	and	antisense	primer	of	S100b	is	as	follows:	5’‐GCC	
CUC	AUU	GAU	GUC	UUC	CAC	CAG	U‐3’	and	5’‐ACU	GGU	GGA	AGA	
CAU CAA UGA GGG C‐3’, respectively. The negative siRNA was used 
as the control siRNA. Rats were anesthetized with sodium pentobar‐
bital	 (40	mg/kg	intraperitoneally)	and	fixed	in	a	stereotaxic	apparatus	
(Stoelting Co, IL, USA). S100b siRNA or control siRNA (1 μg/μL; 10 μL) 
was	injected	into	the	ipsilateral	lateral	ventricle	(−1	mm	anteroposterior,	
2	mm	lateral,	4	mm	deep).	The	location	was	confirmed	by	pontamine	sky	
blue	(0.2%,	1	μL) microinjection after completion of the experiments.
2.12 | Data and statistical analyses
We carried out statistical analyses with SPSS 17.0 software. All data 
were expressed as mean ± SEM. The Morris data were analyzed by 
2‐way repeated‐measures ANOVA. The other values were analyzed 
by 1‐way ANOVA, followed by a post hoc Tukey’s test. The signifi‐
cance level was set as P	<	0.05.
3  | RESULTS
3.1 | Acupuncture improves cognitive functions in 
VaD rats
We examined spatial learning and memory in the MWM to test the 
hypothesis that acupuncture at proper acupoint not non‐acupoint 
could improve cognitive function of VaD rats. As shown in Figure 1, 
rats subjected to 2VO and treated with acupuncture at non‐acupoint 
needed much more time to find the hidden platform (escape latency) 
compared with the sham rats. In contrast, the escape latency was sig‐
nificantly shortened by acupuncture as compared to the 2VO group 
(Figure 1A, P < 0.01). Swim speed was unaffected by surgery or acu‐
puncture, illustrating that four group rats had equivalent motor skills 
(Figure 1B, P	>	0.05).	In	the	probe	trial,	2VO	rats	showed	a	shorter	
time in the target quadrant compared to the sham group. However, 
the decreased time in 2VO group was significantly increased by acu‐
puncture. Significant differences were found between the Acu and 
Non‐acu groups (Figure 1C, P < 0.01). Figure 1D shows representa‐
tive diagrams of search trajectories in MWM.
Taken together, these results demonstrated that acupuncture at 
proper acupoint could ameliorate the behavioral impairment spe‐
cifically. Considering the specificity of acupoint effects has been 
confirmed, we used the sham, 2VO, and Acu group in the following 
experiments.
3.2 | Characterization of molecular events involved 
in neuroprotection by iTRAQ-based quantitative 
proteomic analyses
3.2.1 | Identification of differentially 
expressed proteins
After analyzed as described in the method, a total of 1789 non‐ 
redundant proteins were confidently identified (Data S1). Proteins 
were considered differentially expressed when the expression ratios 
more than 1.2‐fold changes while P‐value	 less	 than	 0.05.	 In	 total,	
there were 221 quantified proteins considered differentially ex‐
pressed (Data S2), with 31 differentially expressed proteins (DEPs) 
appearing in the two comparisons (2VO group vs sham group and 
Acu group vs 2VO group) (Table 2).
3.2.2 | Bioinformatics analysis
As shown in Figure 2, the significantly enriched functional terms were 
performed by a GO analysis. GO analysis consists of three components: 
cellular components (GO‐CC), biological processes (GO‐BP), and mo‐
lecular functions (GO‐MF). GO‐CC reflected DEPs distributed in differ‐
ent cell components. In our study, proteins localized in the extracellular 
exosome had the highest ‐LgP score (Figure 2A). GO‐MF showed that 
proteins related to protein binding and metal ion binding were most 
common (Figure 2B). GO‐BP demonstrated that the oxidation‐reduc‐
tion process and synaptic transmission were the most heavily inter‐
fered biological processes (Figure 2C). Among the biological processes, 
we found most of them related to oxidative stress, apoptosis, or synap‐
tic function, which have been defined as the major processes related to 
acupuncture effect. Therefore, we conducted a Venn diagram to find 
key proteins overlapping among the processes (Figure 2E).
We further analyzed the biological function of DEPs by using 
the	KEGG	database	 and	mapped	 them	 to	54	pathways.	 The	most	
enriched pathways are shown in Figure 2D, including neurodegen‐
eration disease, dopaminergic synapse, oxidative phosphorylation, 
long‐term potentiation, etc
3.3 | Validation of iTRAQ-based proteomics results
Four	DEPs,	namely	S100B,	SOD1,	14‐3‐3e,	and	HMGB1,	were	chosen	
for further validation using western blot (Figure 3). S100B, HMGB1, 
and	14‐3‐3e	expressions	were	markedly	upregulated	in	2VO	rats	com‐
pared to sham rats. Acupuncture notably suppressed the upregulation 
of	S100B	and	HMGB1.	 In	contrast,	 the	expression	 level	of	14‐3‐3e	
was also dramatically increased after acupuncture. SOD1 was mark‐
edly downregulated in the 2VO rats in comparison with the sham 
rats. Acupuncture caused a reversal in the expression of SOD1. Taken 
F I G U R E  1   Acupuncture improves cognitive functions in VaD rats. Quantification of A, escape latency; B, swimming speed for reaching 
the	hidden	platform	during	5	days	in	hidden	platform	trial,	and	C,	the	percentage	of	time	spent	in	the	target	quadrant	in	probe	trial	was	
measured in sham, 2VO, Acu, and Non‐acu rats using water maze task. Values are expressed as means ± SEM (n = 6 for each group). D, 
Typical	swimming	traces	of	all	groups	on	day	5	and	6.	*	and	**	indicate	P <	0.05	and	P < 0.01, respectively, compared with the sham group; 
# and ## indicate P <	0.05	and	P < 0.01, respectively, compared with 2VO group; & and && indicate P <	0.05	and	P < 0.01, respectively, 
compared with Acu group
together, western blot results confirm the consistency between the 
two approaches, despite slight differences between the mean values.
3.4 | Validation of molecular events
Bioinformatics analysis showed that oxidative stress, apoptosis, 
and synaptic function are the major processes related to acupunc‐
ture effect. To verify the three processes, we used DHE staining, 
Nissl staining, and electrophysiology to test ROS production, neu‐
ron	 apoptosis,	 and	 LTP,	 respectively	 (Figure	 4).	 Compared	 to	 the	
sham rats, 2VO rats showed overproduction ROS, less surviving 
neurons, and impaired synaptic function. Acupuncture decreased 
ROS production, increased number of neuron, and enhanced LTP 
(P	<	0.05).
3.5 | Validation of the protein-specific effects via 
used siRNA
Our results have shown that S100b is a key protein regulating 
three major processes, so we choose it to verify its relationship 
with cognitive function. S100b siRNA was microinjected into 
rat lateral ventricle followed by Morris water maze. As shown in 
TA B L E  2   Dysregulated proteins
Accession Protein name Function 2VO/Sham Acu/2VO
Q9JK72 Copper chaperone for superoxide dismutase a 0.762 1.493
O35431 Amyloid	beta	A4	precursor	protein‐binding	family	A	member	2 c 1.475 0.637
P08753 Guanine nucleotide‐binding protein G(k) subunit alpha c 1.445 0.767
Q6PCT8 Succinate dehydrogenase [ubiquinone] cytochrome b small subunit a 1.374 0.784
P14056 Serine/threonine‐protein kinase A‐Raf b 1.347 0.744
Q9ES40 PRA1 family protein 3 a,b 1.264 0.77
P61295 Heart and neural crest derivatives‐expressed protein 2 b 1.261 1.324
P62078 Mitochondrial import inner membrane translocase subunit Tim8 B d 1.227 0.757
Q5XIM4 ATP synthase subunits, mitochondrial d 1.223 0.786
Q5PQJ6 Pyrroline‐5‐carboxylate	reductase	3 a 1.216 1.411
Q63707 Dihydroorotate dehydrogenase (quinone), mitochondrial a,b 1.216 1.224
Q9JLH7 CDK5	regulatory	subunit‐associated	protein	3 c 1.211 1.301
P04631 Protein S100‐B a,b,cc 1.209 0.798
P62260 14‐3‐3	protein	epsilon b,c 1.206 1.846
Q05962 ADP/ATP translocase 1 b 1.203 0.783
Q62760 Mitochondrial import receptor subunit TOM20 homolog d 1.201 1.226
Q9WV97 Mitochondrial import inner membrane translocase subunit Tim9 d 0.791 0.733
Q00959 Glutamate receptor ionotropic, NMDA 2A c 0.782 1.254
P07171 Calbindin c 0.772 1.347
P60570 Pannexin 1 d 0.76 1.873
Q9Z1W6 Protein	LYRIC b 0.75 1.237
Q8R4A1 ERO1‐like protein alpha a 0.749 1.224
Q8VGC3 Voltage‐dependent L‐type calcium channel subunit beta‐2 c 0.744 1.404
Q66H15 Regulator of microtubule dynamics protein 3 b,c 0.724 1.358
P60905 DnaJ	homolog	subfamily	C	member	5 b,c 0.721 1.216
P86173 Actin‐like protein 6B c 0.706 1.368
P63025 Vesicle‐associated membrane protein 3 c 0.68 1.944
P04937 Fibronectin b,c 0.632 2.584
P63159 High mobility group protein B1 b,c 1.243 0.618
Q3MHU3 Putative ATP‐dependent RNA helicase TDRD9 d 0.602 3.406
P10960 Sulfated glycoprotein 1 b 0.571 1.351
Overall upregulation was labeled in bold; overall downregulation was labeled in italics.
aProteins involved in angiogenesis. 
bProteins involved in neurogenesis and synaptogenesis. 
cProteins involved in inflammation. 
dProteins involved in reactive astrocytosis. 
Figures	 5	 and	 6,	 compared	with	 the	 2VO	 group,	 the	 escape	 la‐
tency was reduced in the Acu and 2VO+S100b siRNA group 
(P	<	0.05),	 and	 the	 time	 spent	 in	 the	 target	 quadrant	 increased	
significantly (P	<	0.05).	The	escape	latency	was	prolonged	signifi‐
cantly in the 2VO+Control siRNA group in comparison with the 
Acu and 2VO+S100b siRNA group. Besides, the time spent in the 
target quadrant was decreased in the 2VO + Control siRNA group 
(P	<	0.05).	No	 significant	 changes	were	 found	between	 the	2VO	
group and the 2VO+ Control siRNA group (P	>	0.05).
4  | DISCUSSION
VaD is one of the most common causes of dementia after AD and is 
described as having problems with reasoning, planning, judgment, 
and memory caused by impaired blood flow to the brain. However, 
unlike AD, there are no licensed treatments for VaD.20,21 In this 
study, acupuncture at proper acupoint effectively reduced escape 
latency	by	56.3%‐67.08%	reduction.	Then,	we	used	iTRAQ‐based	
quantitative proteomic analyses to elucidate the molecular events 
F I G U R E  2   Characterization of molecular events involved in neuroprotection by iTRAQ‐based quantitative proteomic analyses. All 
identified proteins were functionally annotated in GO database A‐C, according to their biological process, cellular component, and molecular 
function. D, All identified proteins were functionally annotated in KEGG database. E, Dysregulated proteins functionally annotate to cellular 
processes of oxidative stress, apoptosis, and synaptic function
involved in the beneficial effect of acupuncture. To our knowl‐
edge, this is the first comparative proteomic study to explore the 
mechanisms of acupuncture in VaD rats at protein level. In total, 
we identified 31 DEPs which are susceptible to ischemic injury and 
acupuncture simultaneously—most of them involved in oxidative 
stress, apoptosis, and synaptic function.
Numerous clinical and animal studies have demonstrated that 
acupuncture could improve learning and memory ability.22‒24 In 
our experiments, acupuncture at proper acupoint not non‐acupoint 
improved spatial learning and memory ability of VaD rats, which 
indicated that the effect of acupuncture has acupoint specificity. 
However, the explicit mechanism of acupuncture in treating VaD is 
unclear. In VaD, chronic hypoperfusion leads to a decrease in cerebral 
blood flow, hypoxia, and oxidative stress and triggers inflammatory 
responses. Hypoxia‐induced oxidative stress leads to mitochondrial 
dysfunction, microglial activation, neuronal damage, and apoptosis 
F I G U R E  3   Western blot analysis to verify selected differentially expressed proteins. Candidate proteins were examined and normalized 
to β‐actin	levels	(n	=	6,	hippocampus).	*	and	**	indicate	P <	0.05	and	P < 0.01, respectively, compared with the sham group; # and ## indicate 
P <	0.05	and	P < 0.01, respectively, compared with 2VO group
F I G U R E  4   Molecular and cellular events involved in the protection of acupuncture against ischemic injury. A, 2VO strongly inhibited the 
induction of LTP, and acupuncture reversed the inhibition. B, The evoked synaptic responses were summarized by calculating the average 
of	field	excitatory	postsynaptic	potential	(fEPSP)	slope	5‐60	min	after	high‐frequency	stimulation	(HFS).	C,	Representative	images	of	Nissl	
staining	(hippocampus	CA1	area).	Scale	bars,	50	μm. D, Quantification of the number of Nissl positive neurons. E, Representative images 
of	DHE	staining	(hippocampus	CA1	area).	Scale	bars,	50	μm.	F,	Quantification	of	fluorescence	intensity	of	the	DHE	channel.	n	=	6.	**	and	
***	indicate	P < 0.01 and P < 0.001, respectively, compared with the sham group; ## and ### indicate P < 0.01 and P < 0.001, respectively, 
compared with 2VO groups
via multiple signal pathways.25 The hippocampus, as the core for 
spatial learning and memory, is highly susceptible to hypoperfu‐
sion‐induced lesions. Our previous study proved that acupuncture 
could activate the antioxidant effects or reverse hippocampal mito‐
chondrial dysfunction to prevent spatial memory deficits.26,27 The 
major cellular processes observed in our proteomic changes were 
associated with oxidative stress, apoptosis, and synaptic functions, 
revealing that acupuncture possibly regulates the brain tissue repair 
via regulating oxidative stress, apoptosis, or synaptic functions.
One of the main causes of VaD‐induced cognitive deficits is the 
oxidative stress stimulated by the disruption of cerebral blood flow.28 
Oxidative stress reflects an imbalance between the overproduction of 
ROS and antioxidants. SOD1, one of the most common antioxidases, 
has an ability to remove ROS, which is often inhibited during ischemic 
injury.29,30 It means antioxidant activity is far from enough to completely 
remove excess ROS. Lin and his colleagues demonstrated that acupunc‐
ture could ameliorate learning and memory in rats with ischemic injury 
via increasing the activity of SOD1,31 which is consistent with our results.
Overgeneration of ROS can cause cell death and apoptosis of 
neurons leading to permanent neuronal damage. HMGB1 is im‐
portant for oxidative stress response and cell death signaling. 
HMGB1 has been shown to play an important role in signaling for 
F I G U R E  5   S100B siRNA injection mimicked the antioxidant and neuroprotective potential of acupuncture. Quantification of A, escape 
latency;	B,	swimming	speed	for	reaching	the	hidden	platform	during	5	days	in	hidden	platform	trial,	and	C,	the	percentage	of	time	spent	
in the target quadrant in probe trial was measured in 2VO, Acu, 2VO+S100b siRNA, and 2VO+Control siRNA rats using MWM. Values are 
expressed	as	means	±	SEM	(n	=	6	for	each	group).	D,	Typical	swimming	traces	of	all	groups	on	day	5	and	6.	E,	Representative	images	of	DHE	
staining (hippocampus CA1 area). ## indicate P < 0.01 compared with 2VO group; && indicate P < 0.01 compared with Acu group
mitochondrial dysfunction‐induced apoptosis.32 Ding et al reported 
that	the	HMGB1	together	with	its	receptor	Toll‐like	receptor	4	plays	
a significant role in the pathogenesis of ischemic‐reperfusion injury 
and can induce apoptosis.33 In the present study, acupuncture could 
reverse the expression of HMGB1 and play a role of anti‐apoptotic.
The hippocampus and prefrontal cortex are the most important 
brain regions in the formation of learning and memory. As the part 
of a brain system responsible for learning and memory, hippocam‐
pus is very sensitive to ischemic injury. Learning is widely believed 
to involve synaptic plasticity, employing mechanisms such as those 
used in long‐term potentiation (LTP) and long‐term depression (LTD). 
It is well accepted that the induction of LTP requires activation of 
postsynaptic N‐methyl‐o‐aspartic acid (NMDA) receptors during 
postsynaptic depolarization. This results in a rise in Ca2+ concentra‐
tion, a necessary trigger for LTP.34 In our experiment, the expression 
of NMDA 2A receptor was increased after acupuncture treatment, 
which may be associated with the beneficial effect of acupuncture 
on cognitive function. Voltage‐dependent L‐type calcium (Ca) chan‐
nels (VDCCs), as one of the DEPs, are heteromultimeric proteins 
that are regulated through phosphorylation by cAMP‐dependent 
protein kinase (PKA). In addition, VDCCs have been reported to 
play a critical role in neurotransmitter release evoked by nnAChR 
activation,	and	participate	in	memory	facilitation;	14‐3‐3	is	a	family	
of regulatory proteins enriched at the synapse and plays a positive 
role in learning, memory, and synaptic plasticity. Simsek‐Duran et al 
reported	that	14‐3‐3	is	necessary	for	the	presynaptic	form	of	LTP.35 
In this study, we found that 2VO rats had hippocampal‐dependent 
learning and memory deficits, and the deficits may be due to the 
changes in synaptic ultrastructure, dendritic spine density, and LTP, 
leading to the impairment of synaptic plasticity in the hippocampus. 
Acupuncture	could	regulate	14‐3‐3	expression	to	improve	cognitive	
function.
Among the 31 DEPs, S100B is the only protein regulating three 
major processes. S100B is a well‐known biomarker for the severity of 
brain damage and has been shown to predict prognosis after ischemic 
or traumatic brain injury.36,37 Increasing evidence has shown that an 
increase in the synthesis of S100B is positively associated with the 
neurological deficits,38,39 whereas S100B inhibitors exert potential 
neuroprotective effects against cerebral ischemic injuries.40,41 In our 
experiment, S100b siRNA was injected into rat lateral ventricle fol‐
lowed by Morris water maze to reveal its role in acupuncture in treat‐
ing VaD. Results showed that the injection of siRNA targeting S100b 
had the similar effects to acupuncture on cognition, indicating S100b 
plays an important role in acupuncture neuroprotective effect.
Among the protein list, there are some proteins which do 
not belong to the above three functions, such as pannexin‐1. 
Pannexin‐1 channels could mediate ATP efflux. Prochnow et al 
suggested that ATP release through pannexin‐1 channels plays a 
critical role in maintaining synaptic plasticity in CA1 neurons of 
hippocampus.42 In addition, our previous study has proven the im‐
portance of mitochondrial. In this study, there are a number of 
mitochondrial proteins identified, such as Tim8, Tim9, and Tom20. 
However, these proteins differ in the direction of fold differences, 
and mitochondrial function is not a significantly biology process in 
this study. Therefore, the roles of these proteins in acupuncture 
need further research.
Several studies have demonstrated that the effect of acupunc‐
ture	on	protein	expression	 is	dynamic	 (eg,	HMGB1,	14‐3‐3).	 In	 the	
future research, we will collect samples at different time point after 
acupuncture for data validation. In addition, our results have shown 
that S100b plays a vital role in acupuncture neuroprotective effect. It 
would be worthwhile to further explore the role of S100b‐mediated 
signal pathway in acupuncture treating VaD in our further study.
5  | CONCLUSION
In this study, we applied an iTRAQ‐based proteomic study to in‐
vestigate the molecular mechanism for acupuncture on VaD rats. 
Results suggest that acupuncture improves cognitive function with 
multifunctional mechanisms of action. These findings help us to get 
a deeper understanding of the effect of acupuncture on VaD. Finally, 
the therapeutic efficacy of neuroprotective acupuncture for VaD 
should be further tested.
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